NITD-688 is an orally active pan-serotype inhibitor of the dengue virus NS4B protein. NITD-688 can be used in the research of dengue virus (DENV).
性状
Solid
IC50 & Target[1][2]
NS4B
体外研究(In Vitro)
NITD-688 shows antiviral activity against all four serotypes of dengue virus (DENV), with EC50 values of 8 to 38 nM.NITD-688 shows antiviral activity against DENV-2 infected PBMCs, with an EC50 value of 0.94 nM.NITD-688 directly binds to wild-type but not mutant NS4B protein. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
NITD-688 (30 mg/kg, oral gavage, twice daily for 3 days) demonstrates excellent antiviral efficacy in infected AG129 mice.
NITD-688 (15-300 mg/kg, oral gavage, per day for 7 days) is well tolerated in rats and dogs (toxicology studies). has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Moquin SA, et al. NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models. Sci Transl Med. 2021 Feb 3;13(579):eabb2181.
溶解度数据
In Vitro: DMSO : 100 mg/mL (199.73 mM; ultrasonic and warming and heat to 60°C)配制储备液